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Abstract
Skin infection associated with methicillin-resistant Staphylococcus
aureus (MRSA)-ST398 was detected in a pig-farmer, and MRSA-
ST398 isolates were also detected in nasal samples of the patient
and of 11/12 pigs on his farm. Twelve MRSA isolates were
obtained from skin lesions (n = 6) and nasal samples (n = 6) of
the patient in two sampling moments and 11 MRSA isolates
from nasal samples of pigs. They were typed as t011-SCCme-
cIVa-agrI and t108-SCCmecV-agrI (patient and pigs) and t588-
SCCmecV-agrI (patient). The following resistance genes were
detected (number isolates): tet(K) (1), tet(L) (23), tet(M) (13),
erm(A) (13), erm(C) (13), msr(A) (11), lnu(A) (21), aph(2¢¢)-
acc(6¢) (3), ant(4¢) (13), aph(3¢) (12), dfrS1 (15) and dfrK (22).
Seventeen human and animal MRSA-ST398 isolates showed
indistinguishable PFGE patterns (A1-spa-t011 or B2-spa-t108)
and similar phenotypic-genotypic characteristics, including the
presence of the lnu(A) gene, associated with lincomycin resis-
tance. Potential pig-to-human transference of ST398 is suggested
in this study. The ﬁrst detection of the lnu(A) gene in MRSA-
ST398 is reported.
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Methicillin-resistant Staphylococcus aureus (MRSA) of
sequence type ST398 has been identiﬁed either colonizing
or causing infections in animals and humans, and has been
found to cause diseases related to occupational contact with
pigs. The prevalence of colonization by these strains in
those who work with pigs has been proved to be higher
than in people without this risk factor [1]. MRSA-ST398 is
characterized by its resistance to tetracycline, one of the
main antibiotics used in pig farming. Moreover, an unusual
resistance phenotype showing clindamycin resistance but
erythromycin susceptibility has been reported in a few
MRSA-ST398 isolates [2–5]. Recently, this phenotype has
been associated in some strains with the presence of plas-
mid-borne resistance genes vga(A) or vga(C) [6]. The
expression of lincomycin-modifying enzymes could confer
resistance to lincomycin but not to erythromycin, and this
mechanism is infrequent in S. aureus, and has not been
reported so far in MRSA-ST398 isolates. The aim of this
study was to perform the genetic characterization of 23
MRSA isolates (12 recovered from a patient with skin
lesions and 11 from pigs on the farm where the patient
worked) in order to determine the possible MRSA
animal-to-human transmission, and to characterize the
mechanism of lincomycin resistance detected in 21 of 23
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of these MRSA isolates (12 from a human and nine from
pigs).
A 54-year-old patient, who worked on a pig farm in Spain,
presented skin lesions, diagnosed as psoriasis by the
dermatologist. In order to know whether superinfection with
bacteria or fungi could be also involved, three samples from
lesions (scalp, dorsum of the nose and chin) and moreover
two from both nasal ducts were obtained (October 2008,
period 1) and submitted to microbiological analysis. Heavy
growth of MRSA isolates was obtained in all ﬁve tested sam-
ples of the patient and they were identiﬁed by classical
microbiological tests and conﬁrmed by detection of nuc and
mecA genes by PCR [7]. Five MRSA isolates (one per sam-
ple) were further characterized.
Nasal samples of two family members of the patient (wife
and son) who did not live close to the farm and had no con-
tact with pigs were also tested in October 2008, and they
were negative for S. aureus and MRSA.
The patient was treated with an antiseptic gel for scalp
and beard washing, a metilprednisole solution and a cream
with betametasone and fusidic acid for cutaneous lesions,
and nasal MRSA decolonization with mupirocin. The patient
had some clinical improvement of the lesions in the next
weeks, although they were not resolved, and he returned to
a new control with his dermatologist 3 months later (January
2009, period 2). New samples were then obtained from
three skin lesions (ear canal, hand and chin) and from both
nasal ducts, and they were submitted to microbiological
study. MRSA isolates were recovered again from skin sam-
ples (three isolates, one isolate per sample) and nasal sam-
ples (four isolates, two isolates per sample).
In addition, nasal swabs from 12 pigs on the farm where
the patient worked were randomly obtained (January 2009,
period 2). They were inoculated in brain-heart-infusion-broth
(BHI, BD) containing 6.5% NaCl and incubated at 35C for
24 h, and later they were seeded on oxacillin-resistance-
screening agar plates (ORSAB, Oxoid) with oxacillin (2 mg/
L), and were incubated at 35C for 36 h. MRSA was
detected in 11 of these 12 animals (91.6%), and one MRSA
isolate per animal was further characterized.
Antimicrobial susceptibility to 23 antibiotics was deter-
mined by the VITEK-2 system (bioMe´rieux, Marcy l’ Etoile,
France) and by disk-diffusion assay in the 23 recovered MRSA
isolates (12 from the patient and 11 from the pigs) following
CLSI recommendations [8]. The tested antibiotics were: peni-
cillin, oxacillin, cefoxitin, tetracycline, erythromycin, telithro-
mycin, clindamycin, lincomycin, gentamicin, tobramycin,
sulfamethoxazole-trimethoprim, ciproﬂoxacin, levoﬂoxacin,
vancomycin, teicoplanin, quinupristin/dalfopristin, linezolid,
fosfomycin, fusidic acid, mupirocin, nitrofurantoin, rifampin and
kanamycin. Staphylococcus aureus ATCC 29213 and Enterococ-
cus faecalis ATCC 29212 were used as control strains. Linco-
mycin and clindamycin susceptibility was also studied by the
agar dilution method [8,9]. CLSI breakpoints [8] were used for
all antibiotics, with two exceptions: lincomycin breakpoints
were considered as recommended by the Societe´ Franc¸aise de
Microbiologie [9], and mupirocin breakpoints as considered by
Oliveria et al. 2007 [10]. The presence of erm(A), erm(B),
erm(C), msr(A), lnu(A), lnu(B), lnu(C), lnu(D), cfr, vga(C), lsa(B),
tet(K), tet(L), tet(M), tet(O), aph(2¢¢)-acc(6¢), ant(4¢), aph(3¢),
dfrS1, dfrD and dfrK antimicrobial resistance genes was studied
by PCR and sequencing [7,11]. MRSA isolates of human and
animal origin were typed (PFGE, MLST, SCCmec-, spa- and agr-
typing) as previously described [7,12–14]. Characteristics of
MRSA of human and animal origin are included in Table 1.
All ﬁve MRSA isolates recovered from the patient in per-
iod 1 before treatment (three from skin lesions and two
from nasal samples) and four of the seven isolates obtained
after the treatment (three from lesions and one from nasal
sample) were typed as MRSA-ST398-t011, SCCmec-IVa and
agr-I and showed resistance to tetracycline, erythromycin,
telithromycin, clindamycin, lincomycin, tobramycin, kana-
mycin and sulfamethoxazole-trimethoprim (Table 1).
The remaining three MRSA nasal isolates obtained from
the patient after treatment were typed as ST398-t108-
SCCmecV-agrI (two isolates) and ST398-t588-SCCmecV-agrI
(one isolate), and showed different antimicrobial resistance
phenotypes and genotypes (Table 1).
Eleven MRSA isolates were recovered from pigs. Seven of
them were typed as ST398-t108-SCCmecV-agrI and four
MRSA isolates of pig origin were typed as ST398-t011-
SCCmecIVa-agrI (Table 1).
Twenty-one of 23 MRSA isolates obtained in this study
(12/12 isolates from the patient and 9/11 isolates of animal
origin) presented a high level of resistance to lincomycin
and harboured the lnu(A) gene. Thirteen of these isolates
showed resistance to erythromycin/clindamycin/lincomycin
(ST398-t011-SCCmecIVa-agrI, ST398-t108-SCCmecV-agrI and
ST398-t588-SCCmecV-agrI) and harboured the erm(A) and
erm(C) genes, in addition to the lnu(A) gene; the remaining
eight isolates presented an unusual erythromycin/clindamy-
cin-susceptibility and lincomycin-resistance phenotype
(ST398-t108-SCCmecV-agrI) and lacked erm genes
(Table 1).
Three unrelated pulsotypes (A–C) were identiﬁed after
analysis of PFGE-patterns of all human and animal MRSA iso-
lates [15]. In addition, pulsotype A comprised ﬁve subtypes
(A1–A5) and pulsotype B two subtypes (B1 and B2) (Fig. 1).
All MRSA isolates with spa-type t011 were ascribed to puls-
otype-A, those with t108 to pulsotype-B, and the MRSA iso-
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late t588 to pulsotype-C (Fig. 1 and Table 1). It is important
to remark that MRSA isolates typed as PFGE/A1-spa-t011
and PFGE/B2-spa-t108 were recovered both from pigs and
the patient (nasal or skin lesion samples), suggesting the pos-
sible animal-to-human MRSA transmission. All lnu(A)-contain-
ing MRSA isolates with the erythromycin/clindamycin-
susceptible and lincomycin-resistance phenotype were
ascribed to the pulsotype B2.
MRSA isolates of human and animal origin were tested by
PCR for the genes encoding the Panton-Valentine-leukocidin,
toxic-shock-syndrome-toxin 1, and exfoliative-toxin A, B and
D [7,16], and negative results were obtained in all cases. The
presence of PVL is not frequently found among MRSA-ST398
[17]. However, the lnu(A) gene has been previously detected
in two MRSA PVL-positive isolates [18].
Therefore, the MRSA isolates investigated in this study
were recovered from a human patient and from some pigs
on his farm. Therapy with topical compounds (fusidic acid or
mupirocin) might improve clinical symptoms but the efﬁcacy
could be low in people with close contact with MRSA-colo-
nized animals [19], as is corroborated in this study. People
who are in contact with pigs seem to have a signiﬁcant bac-
terial load of MRSA [1] and can serve as a reservoir, which
may have important epidemiological and clinical implications.
Moreover, most pigs tested in this study (11/12, 91.7%) were
MRSA-ST398 carriers. These results seem to be usual
according to the high frequencies of detection recently found
among slaughter pigs in Spain [7], and also to the high
frequencies revealed in farm dust samples in some European
countries, such as Spain and Germany [20].
The detection of the gene lnu(A) in MRSA-ST398 isolates
from a human and some pigs is a novel observation. This
gene encodes a lincomycin-nucleotidyltransferase and confers
varying levels of resistance to different lincosamides such as
pirlimycin and lincomycin [21], but not to clindamycin. In our
study, this gene conferred high level of lincomycin resistance,
as MIC was >128 mg/L in these isolates and some isolates
showed also clindamycin resistance by the presence of erm
genes. The lnu(A) gene was widely spread in the farm
sampled, being detected in MRSA-ST398 isolates with differ-
ent spa-types and pulsotypes. This gene is uncommon, and it
has been generally found in strains resistant to both macro-
lides and lincosamides [11,22]. Lincomycin has occasionally
been used in the animal industry and lnu(A) has already been
detected in methicillin-susceptible S. aureus (MSSA) isolates
from bovine origin [23]. However, as far as we know, it has
not been reported in MRSA of the ST398 lineage.
In summary, the animal-to-human transmission of MRSA-
ST398 seems evident in this study. Indistinguishable PFGE
patterns and similar phenotypic and genotypic characteristics
have been detected in MRSA isolates obtained from a farmer
and from some of the pigs on the farm where he worked.
The transmission of MRSA-ST398 isolates containing lnu(A)
and other resistance genes between animals and humans
could compromise treatment of infections caused by this
microorganism. In addition, the high diversity of resistance
genes harboured by most of the human and animal isolates is
of great interest.
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FIG. 1. PFGE patterns of chromosomal DNA digested with the ApaI
enzyme of MRSA isolates recovered from the patient and some ani-
mals in this study. Line 1, t011 (pulsotype A2); lines 2–6, t011 (puls-
otype A1); line 7, t011 (pulsotype A3); line 8, t011 (pulsotype A4);
line 9, t011 (pulsotype A5); line 10, t108 (pulsotype B1); lines 11–17,
t108 (pulsotype B2); line 18, t588 (pulsotype C).
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